Anpario’s (ANP) House Stock Rating Reaffirmed at Shore Capital Group

Anpario (LON:ANP)‘s stock had its “house stock” rating restated by stock analysts at Shore Capital Group in a research note issued to investors on Monday,London Stock Exchange reports.

Separately, Canaccord Genuity Group reissued a “buy” rating and set a GBX 570 price objective on shares of Anpario in a report on Friday, June 26th. One equities research analyst has rated the stock with a Buy rating, According to data from MarketBeat, Anpario has a consensus rating of “Buy” and an average target price of GBX 570.

Anpario Stock Performance

Shares of LON:ANP opened at GBX 530 on Monday. Anpario has a twelve month low of GBX 391.11 and a twelve month high of GBX 580. The firm has a market cap of £86.32 million, a PE ratio of 13.97 and a beta of 1.08. The company has a debt-to-equity ratio of 0.60, a quick ratio of 5.16 and a current ratio of 4.50. The business has a fifty day moving average of GBX 529.37 and a 200-day moving average of GBX 520.54.

Anpario declared that its Board of Directors has approved a share buyback plan on Monday, April 27th that permits the company to repurchase 0 outstanding shares. This repurchase authorization permits the company to purchase shares of its stock through open market purchases. Stock repurchase plans are generally a sign that the company’s board believes its shares are undervalued.

About Anpario

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.